This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Nursing Management of Treatment-Related Side Effects in Metastatic Prostate Cancer

Nursing Management of Treatment-Related Side Effects in Metastatic Prostate Cancer

Format

Webcast

Time to Complete

1 hour

Released

March 29, 2019

Expires

March 29, 2020
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE Contact Hour
1.00 / AANP Contact Hour (0.60 pharmacology hours)

Accredited Provider

This activity is jointly provided by Global Education Group and MCM Education.

Commercial Supporter

This activity is supported by educational grants from Astellas Pharma US, Sanofi Genzyme, and AbbVie, Inc.

Program Description

Treatment for prostate cancer has expanded and improved in recent years, but many patients continue to live with the long-term sequelae of the disease and treatment-related side effects. There are numerous treatment options available for both hormone-sensitive and castration-resistant metastatic prostate cancer, and oncology nurses must be knowledgeable about these and their wide range of adverse effects. This activity will examine the prevention and management of long and short-term side effects, ADT-related bone loss and the risk of osteoporosis, bone fragility risk in patients with bone metastases, patient education, and individualized supportive care.

Intended Audience

This educational activity is designed to address the needs of oncology nurses, NPs, and other health care providers who encounter patients with mPRCA.

Educational Objectives

Upon completion of this educational activity, participants should be able to:

  • Outline individualized plans for preventing and managing treatment side effects for patients with metastatic hormone-sensitive prostate cancer using shared decision making.
  • Outline individualized plans for preventing and managing treatment side effects for patients with metastatic castration-resistant prostate cancer using shared decision making.
  • Discuss agents used to support bone health in patients with metastatic prostate cancer.
  • Describe individualized supportive care for patients with metastatic prostate cancer.

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Faculty

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity.

PRESENTER
Victoria J. Sinibaldi, RN-C, MS, ARNP, GRNP

Nurse Practitioner Research Program Coordinator, Genitourinary Malignancies
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Research Associate in Oncology
Research Associate in Urology
The Johns Hopkins University School of Medicine
Baltimore, MD

Ms. Sinibaldi has nothing to disclose.

OTHER CONTRIBUTING FACULTY
Frank dela Rama, RN, MS, AOCNS, AGN-BC

Clinical Nurse Specialist, Oncology/Genomics
CANCER CARE
Palo Alto Medical Foundation
Palo Alto, CA

Mr. dela Rama has nothing to disclose.

Brigid S. Miralda, RN, MSN, FNP
UCSF Helen Diller Family Comprehensive Cancer Center
San Francisco, CA

Ms. Miralda has nothing to disclose.

Accredited Provider Disclosures

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN, has nothing to disclose
Kristin Delisi, NP, has nothing to disclose
Lindsay Borvansky has nothing to disclose
Andrea Funk has nothing to disclose
Liddy Knight has nothing to disclose
Ashley Cann has nothing to disclose
Kathleen Hines has nothing to disclose

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and MCM Education. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this enduring material for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CE for Nurse Practitioners

Accreditation Statement


This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Global Education Group and MCM Education. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024.

Designation Statement

This activity is approved for 1.00 contact hour, which includes 0.60 hours of pharmacology.
Activity ID #2699E.
This activity was planned in accordance with AANP CE Standards and Policies.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and MCM Education do not recommend the use of any agent outside of the labeled indications.

Disclaimer

©2019 MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, Global Education Group, Astellas Pharma US, Sanofi Genzyme, or AbbVie, Inc. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

Instructions

To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For information about the approval of this program, please contact Global at 303-395-1782 or cme@globaleducationgroup.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue